Overcome Biochemical Aspirin Resistance Through Cilostazol Combination

NCT00446641 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

244

Enrollment

OTHER

Sponsor class

Conditions

Cerebral Infarction

Interventions

DRUG: Cilostazol
DRUG: placebo

Sponsor

Asan Medical Center

Collaborators

[object Object]